دورية أكاديمية
أعرض في EDS

Marine Bromotyrosine Derivatives in Spotlight: Bringing Discoveries and Biological Significance.

التفاصيل البيبلوغرافية
العنوان: Marine Bromotyrosine Derivatives in Spotlight: Bringing Discoveries and Biological Significance.
المؤلفون: Ferreira Montenegro P; Marine Natural Products Team, Institut de Chimie de Nice, Université Côte d'Azur, CNRS UMR 7272, 06108 Nice, France., Pham GN; Marine Natural Products Team, Institut de Chimie de Nice, Université Côte d'Azur, CNRS UMR 7272, 06108 Nice, France., Abdoul-Latif FM; Medicinal Research Institute, Center for Studies and Research of Djibouti, IRM-CERD, Route de l'Aéroport, Haramous, Djibouti City P.O. Box 486, Djibouti., Taffin-de-Givenchy E; Marine Natural Products Team, Institut de Chimie de Nice, Université Côte d'Azur, CNRS UMR 7272, 06108 Nice, France., Mehiri M; Marine Natural Products Team, Institut de Chimie de Nice, Université Côte d'Azur, CNRS UMR 7272, 06108 Nice, France.
المصدر: Marine drugs [Mar Drugs] 2024 Mar 14; Vol. 22 (3). Date of Electronic Publication: 2024 Mar 14.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101213729 Publication Model: Electronic Cited Medium: Internet ISSN: 1660-3397 (Electronic) Linking ISSN: 16603397 NLM ISO Abbreviation: Mar Drugs Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI, [2003]-
مواضيع طبية MeSH: Bandages* , Porifera*, Tyrosine/*analogs & derivatives, Humans ; Animals
مستخلص: The Verongida order comprises several sponge families, such as Aplysinellidae, Aplysinidae, Ianthellidae, and Pseudoceratinidae, reported for producing bromotyrosine-derived compounds. First identified in 1913, bromotyrosine derivatives have since captivated interest notably for their antitumor and antimicrobial properties. To date, over 360 bromotyrosine derivatives have been reported. Our review focuses specifically on bromotyrosine derivatives newly reported from 2004 to 2023, by summarizing current knowledge about their chemical diversity and their biological activities.
Competing Interests: The authors declare no conflicts of interest.
References: Mar Drugs. 2019 May 30;17(6):. (PMID: 31151240)
Chem Biodivers. 2008 Jul;5(7):1313-20. (PMID: 18649318)
J Nat Prod. 1995 Jul;58(7):971-85. (PMID: 7561906)
J Nat Prod. 1997 Jun;60(6):614-5. (PMID: 9214734)
Bioorg Med Chem Lett. 2016 Jan 15;26(2):499-504. (PMID: 26711149)
J Org Chem. 2007 Feb 16;72(4):1211-7. (PMID: 17256905)
J Nat Prod. 2017 Jan 27;80(1):215-219. (PMID: 28085276)
Planta Med. 2006 Apr;72(5):437-41. (PMID: 16557458)
Chem Pharm Bull (Tokyo). 2016;64(3):258-62. (PMID: 26936051)
Free Radic Res. 2019 Oct;53(9-10):1019-1034. (PMID: 31530194)
Nat Prod Res. 2008;22(14):1257-63. (PMID: 18932089)
J Chem Ecol. 2008 Sep;34(9):1242-52. (PMID: 18679752)
Bioorg Med Chem Lett. 2009 Mar 1;19(5):1337-9. (PMID: 19201605)
Bioorg Med Chem Lett. 2014 Aug 1;24(15):3537-40. (PMID: 24948562)
Mar Drugs. 2013 Apr 17;11(4):1271-87. (PMID: 23595055)
Chem Biodivers. 2012 Aug;9(8):1436-51. (PMID: 22899605)
Bioorg Med Chem. 2010 Feb;18(3):1297-311. (PMID: 20061160)
J Nat Prod. 2017 Feb 24;80(2):235-240. (PMID: 28191971)
Mar Drugs. 2020 May 21;18(5):. (PMID: 32455754)
J Org Chem. 2005 Mar 4;70(5):1893-6. (PMID: 15730316)
J Nat Prod. 2011 May 27;74(5):1275-80. (PMID: 21488653)
J Nat Prod. 2008 Jun;71(6):1066-7. (PMID: 18393464)
J Nat Prod. 2008 Aug;71(8):1464-7. (PMID: 18656986)
Mar Drugs. 2019 Feb 12;17(2):. (PMID: 30759850)
J Nat Prod. 2010 Mar 26;73(3):365-72. (PMID: 20102170)
Appl Microbiol Biotechnol. 2014 Apr;98(8):3475-94. (PMID: 24562325)
Bioorg Med Chem Lett. 2011 Jan 15;21(2):846-8. (PMID: 21190857)
Fitoterapia. 2018 Apr;126:16-21. (PMID: 29221701)
J Chem Ecol. 2016 Jan;42(1):60-70. (PMID: 26757731)
Org Lett. 2019 Nov 1;21(21):8824-8826. (PMID: 31633367)
J Nat Prod. 2020 May 22;83(5):1532-1540. (PMID: 32357010)
J Nat Prod. 2012 Apr 27;75(4):759-63. (PMID: 22364566)
Alkaloids Chem Biol. 2005;61:59-262. (PMID: 16173400)
Org Biomol Chem. 2011 Oct 7;9(19):6755-60. (PMID: 21850326)
Bioorg Med Chem Lett. 2008 Dec 15;18(24):6414-8. (PMID: 18990572)
Mar Drugs. 2018 Nov 23;16(12):. (PMID: 30477099)
Mar Drugs. 2013 Aug 26;11(9):3168-85. (PMID: 24065159)
J Nat Prod. 2009 Jun;72(6):1178-83. (PMID: 19459694)
Eur J Mass Spectrom (Chichester). 2012;18(3):333-43. (PMID: 22837437)
Molecules. 2019 Sep 26;24(19):. (PMID: 31561445)
Chem Biodivers. 2020 Oct;17(10):e2000335. (PMID: 32697400)
Biomolecules. 2021 Feb 10;11(2):. (PMID: 33578987)
Nat Prod Commun. 2015 Jan;10(1):219-31. (PMID: 25920247)
Mar Drugs. 2015 Mar 16;13(3):1389-409. (PMID: 25786066)
J Nat Prod. 2014 Sep 26;77(9):2105-13. (PMID: 25181423)
J Nat Prod. 2012 Dec 28;75(12):2132-43. (PMID: 23215158)
Bioorg Med Chem Lett. 2010 Aug 1;20(15):4569-72. (PMID: 20584605)
Mar Drugs. 2021 Jul 23;19(8):. (PMID: 34436248)
Chem Pharm Bull (Tokyo). 2012;60(12):1599-601. (PMID: 23207640)
J Antibiot (Tokyo). 2009 Jul;62(7):393-5. (PMID: 19557033)
J Nat Prod. 2007 Nov;70(11):1827-9. (PMID: 17988096)
J Nat Prod. 2012 Mar 23;75(3):502-6. (PMID: 22236331)
J Nat Prod. 2010 May 28;73(5):985-7. (PMID: 20462236)
Biomolecules. 2019 Dec 08;9(12):. (PMID: 31817954)
J Nat Prod. 2014 May 23;77(5):1210-4. (PMID: 24758268)
Beilstein J Org Chem. 2015 Nov 26;11:2334-42. (PMID: 26734082)
ACS Omega. 2017 Jul 31;2(7):3494-3501. (PMID: 30023696)
Curr HIV Res. 2023;21(6):331-346. (PMID: 38047360)
Bioorg Med Chem. 2007 Aug 1;15(15):5275-82. (PMID: 17512741)
J Nat Prod. 2013 Sep 27;76(9):1731-6. (PMID: 23964644)
J Nat Prod. 2013 Apr 26;76(4):516-23. (PMID: 23489291)
Mar Drugs. 2011;9(10):1902-1913. (PMID: 22073002)
Planta Med. 2008 Apr;74(5):555-9. (PMID: 18401846)
J Nat Prod. 2003 Nov;66(11):1495-8. (PMID: 14640526)
Mar Drugs. 2019 Jun 27;17(7):. (PMID: 31252563)
J Nat Prod. 2009 Feb 27;72(2):290-4. (PMID: 19206511)
J Nat Prod. 2015 Aug 28;78(8):2051-6. (PMID: 26237370)
J Nat Prod. 2012 May 25;75(5):1001-5. (PMID: 22515429)
Mar Drugs. 2018 Apr 27;16(5):. (PMID: 29702602)
Mar Drugs. 2021 Mar 06;19(3):. (PMID: 33800819)
فهرسة مساهمة: Keywords: Verongida; anticancer activities; antimicrobial activities; bromotyrosine derivatives; marine sponges
المشرفين على المادة: 0 (bromotyrosine)
42HK56048U (Tyrosine)
تواريخ الأحداث: Date Created: 20240327 Date Completed: 20240328 Latest Revision: 20240329
رمز التحديث: 20240329
مُعرف محوري في PubMed: PMC10971822
DOI: 10.3390/md22030132
PMID: 38535473
قاعدة البيانات: MEDLINE
الوصف
تدمد:1660-3397
DOI:10.3390/md22030132